The Range of 2.2-3.3 mg/gCr of Pregnanetriol in the First Morning Urine Sample as an Index of Optimal Control in CYP21 Deficiency.

MLA

Izawa, Masako, et al. “The Range of 2.2-3.3 Mg/GCr of Pregnanetriol in the First Morning Urine Sample as an Index of Optimal Control in CYP21 Deficiency.” Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology, vol. 17, no. 3, 2008, pp. 75–80. EBSCOhost, https://doi.org/10.1297/cpe.17.75.

APA

Izawa, M., Aso, K., Higuchi, A., Ariyasu, D., & Hasegawa, Y. (2008). The Range of 2.2-3.3 mg/gCr of Pregnanetriol in the First Morning Urine Sample as an Index of Optimal Control in CYP21 Deficiency. Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology, 17(3), 75–80. https://doi.org/10.1297/cpe.17.75

Chicago

Izawa, Masako, Keiko Aso, Asako Higuchi, Daisuke Ariyasu, and Yukihiro Hasegawa. 2008. “The Range of 2.2-3.3 Mg/GCr of Pregnanetriol in the First Morning Urine Sample as an Index of Optimal Control in CYP21 Deficiency.” Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology 17 (3): 75–80. doi:10.1297/cpe.17.75.